Maj Invest Holding A S raised its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 0.4% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 319,050 shares of the company's stock after purchasing an additional 1,224 shares during the quarter. HCA Healthcare comprises 4.3% of Maj Invest Holding A S's holdings, making the stock its 14th biggest position. Maj Invest Holding A S owned approximately 0.13% of HCA Healthcare worth $122,228,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. ORG Partners LLC increased its stake in shares of HCA Healthcare by 27.9% in the second quarter. ORG Partners LLC now owns 142 shares of the company's stock worth $55,000 after acquiring an additional 31 shares during the period. Avantax Advisory Services Inc. raised its stake in shares of HCA Healthcare by 0.4% during the 1st quarter. Avantax Advisory Services Inc. now owns 8,077 shares of the company's stock valued at $2,791,000 after buying an additional 32 shares during the last quarter. Glenview Trust co grew its holdings in HCA Healthcare by 2.3% during the first quarter. Glenview Trust co now owns 1,451 shares of the company's stock worth $501,000 after acquiring an additional 32 shares during the period. Horizon Investments LLC boosted its position in HCA Healthcare by 1.1% in the 1st quarter. Horizon Investments LLC now owns 3,175 shares of the company's stock worth $1,097,000 after purchasing an additional 33 shares in the last quarter. Finally, Sivia Capital Partners LLC increased its holdings in shares of HCA Healthcare by 5.5% during the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company's stock valued at $241,000 after purchasing an additional 33 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company's stock.
Wall Street Analysts Forecast Growth
A number of research firms have weighed in on HCA. Wall Street Zen raised shares of HCA Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, July 5th. Mizuho increased their price target on HCA Healthcare from $425.00 to $475.00 and gave the stock an "outperform" rating in a research report on Friday. Jefferies Financial Group upped their target price on HCA Healthcare from $400.00 to $485.00 in a research note on Wednesday, October 15th. Barclays upped their price objective on shares of HCA Healthcare from $390.00 to $445.00 and gave the stock an "overweight" rating in a research report on Thursday, September 18th. Finally, Royal Bank Of Canada cut their target price on shares of HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating for the company in a research note on Monday, July 28th. One research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and nine have given a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $437.19.
View Our Latest Stock Analysis on HCA
HCA Healthcare Stock Up 1.6%
Shares of NYSE HCA opened at $433.18 on Tuesday. The stock has a market capitalization of $101.36 billion, a price-to-earnings ratio of 18.21, a price-to-earnings-growth ratio of 1.35 and a beta of 1.40. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $439.01. The firm has a 50-day simple moving average of $411.05 and a 200-day simple moving average of $379.33.
HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings data on Friday, July 25th. The company reported $6.84 EPS for the quarter, beating analysts' consensus estimates of $6.20 by $0.64. The company had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. HCA Healthcare's quarterly revenue was up 6.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, equities research analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.
HCA Healthcare Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th were issued a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a dividend yield of 0.7%. The ex-dividend date was Tuesday, September 16th. HCA Healthcare's payout ratio is currently 12.11%.
Insider Activity
In related news, EVP Michael S. Cuffe sold 3,836 shares of the firm's stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the completion of the sale, the executive vice president directly owned 31,503 shares in the company, valued at approximately $13,194,716.52. This trade represents a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 1.30% of the company's stock.
HCA Healthcare Profile
(
Free Report)
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.